Published in Br J Cancer on December 06, 2011
Substantial contribution of extrinsic risk factors to cancer development. Nature (2015) 2.46
Seasonal variation in diagnosis of invasive cutaneous melanoma in Eastern England and Scotland. Cancer Epidemiol (2015) 1.39
A methodologic framework to evaluate the number of cancers attributable to lifestyle and environment in Alberta. CMAJ Open (2016) 1.09
AACR Cancer Progress Report 2014. Clin Cancer Res (2014) 1.05
Cancers in Australia attributable to exposure to solar ultraviolet radiation and prevented by regular sunscreen use. Aust N Z J Public Health (2015) 0.90
Vitamin D and the skin: Focus on a complex relationship: A review. J Adv Res (2014) 0.88
Skin cancer prevention practices among malignant melanoma survivors: a systematic review. J Cancer Res Clin Oncol (2015) 0.85
Ultraviolet damage to the eye revisited: eye-sun protection factor (E-SPF®), a new ultraviolet protection label for eyewear. Clin Ophthalmol (2013) 0.82
Scottish adolescents' sun-related behaviours, tanning attitudes and associations with skin cancer awareness: a cross-sectional study. BMJ Open (2014) 0.81
Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection. Curr Epidemiol Rep (2016) 0.81
Malignant melanoma: a pictorial review. Ulster Med J (2014) 0.80
Impaired light detection of the circadian clock in a zebrafish melanoma model. Cell Cycle (2015) 0.78
Community-wide Interventions to Prevent Skin Cancer: Two Community Guide Systematic Reviews. Am J Prev Med (2016) 0.78
Skin cancer, irradiation, and sunspots: the solar cycle effect. Biomed Res Int (2014) 0.77
Fyn is a redox sensor involved in solar ultraviolet light-induced signal transduction in skin carcinogenesis. Oncogene (2015) 0.76
Paradoxes in dermatology. Indian Dermatol Online J (2013) 0.75
Knowledge and attitudes of UK university students in relation to ultraviolet radiation (UVR) exposure and their sun-related behaviours: a qualitative study. BMJ Open (2017) 0.75
A Left-Sided Prevalence of Lentigo Maligna: A UK Based Observational Study and Review of the Evidence. Dermatol Res Pract (2015) 0.75
Head and neck melanoma (excluding ocular melanoma): United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol (2016) 0.75
Cancer incidence attributable to lifestyle and environmental factors in Alberta in 2012: summary of results. CMAJ Open (2017) 0.75
Aware, motivated and striving for a 'safe tan': an exploratory mixed-method study of sun-protection during holidays. Health Psychol Behav Med (2017) 0.75
Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol (2004) 5.49
A review of human carcinogens--part D: radiation. Lancet Oncol (2009) 4.22
Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. Arch Dermatol (1999) 2.92
Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer (2003) 2.13
How much melanoma is caused by sun exposure? Melanoma Res (1993) 1.95
Cutaneous malignant melanoma in Europe. Eur J Cancer (2004) 1.88
Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet (2002) 1.53
Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol (1999) 1.43
IARC monographs on the evaluation of carcinogenic risks to humans. Solar and ultraviolet radiation. IARC Monogr Eval Carcinog Risks Hum (1992) 1.36
Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer (1991) 1.29
Site distribution of cutaneous melanoma in Queensland. Int J Cancer (1993) 1.22
Melanoma incidence has risen in Europe. BMJ (2005) 1.06
Avoidable cancers in the Nordic countries. Radiation. APMIS Suppl (1997) 0.83
Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet (2003) 5.39
Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer (2011) 3.23
Cervical sampling devices. BMJ (1996) 2.74
Sentinel node biopsy in cutaneous melanoma: time for consensus to better inform patient choice. Br J Dermatol (2015) 2.61
Effect of smoking cessation on cervical lesion size. Lancet (1996) 2.35
16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer (2011) 2.32
A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32
Trends in cervical cancer mortality. Lancet (1991) 2.28
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer (2012) 2.15
Accelerated decline in cervical cancer mortality in England and Wales. Lancet (1995) 1.95
APC in the regulation of intestinal crypt fission. J Pathol (1998) 1.73
Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer (1996) 1.71
Comparing the performance of six human papillomavirus tests in a screening population. Br J Cancer (2013) 1.68
Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant (2008) 1.65
Differential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma. J Clin Pathol (1999) 1.54
Cancer mortality in the United Kingdom: projections to the year 2025. Br J Cancer (2008) 1.52
Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol (2004) 1.51
Sampling methods for cervical smears. Acta Cytol (1992) 1.45
2. Tobacco-attributable cancer burden in the UK in 2010. Br J Cancer (2011) 1.45
The impact of Jade Goody's diagnosis and death on the NHS Cervical Screening Programme. J Med Screen (2012) 1.44
PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J Cell Sci (2001) 1.42
Exposure to the sun and sunbeds and the risk of cutaneous melanoma in the UK: a case-control study. Eur J Cancer (2004) 1.40
HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Br J Cancer (2011) 1.38
Ingested arsenic, keratoses, and bladder cancer. Am J Epidemiol (1992) 1.37
Genetics of risk factors for melanoma: an adult twin study of nevi and freckles. J Natl Cancer Inst (2000) 1.34
Women's understanding of a "normal smear test result": experimental questionnaire based study. BMJ (2001) 1.33
Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years. Br J Cancer (2013) 1.33
Could HPV testing become the sole primary cervical screening test? J Med Screen (2002) 1.31
The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol (2002) 1.29
1. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer (2011) 1.26
Predicting the impact of the screening programme for colorectal cancer in the UK. J Med Screen (2008) 1.25
Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence. Br J Cancer (2004) 1.20
Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol (2004) 1.20
Risk factors for invasive cervix cancer in young women. Eur J Cancer (1996) 1.19
Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study. Br J Cancer (2010) 1.18
3. Cancers attributable to consumption of alcohol in the UK in 2010. Br J Cancer (2011) 1.16
8. Cancers attributable to overweight and obesity in the UK in 2010. Br J Cancer (2011) 1.15
The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia. Br J Cancer (1998) 1.15
Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK. Br J Cancer (2010) 1.09
A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer (2000) 1.08
Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study. Br J Cancer (2012) 1.07
5. Cancers attributable to dietary factors in the UK in 2010. II. Meat consumption. Br J Cancer (2011) 1.07
Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen? Br J Cancer (2006) 1.06
Solar keratoses: a risk factor for melanoma but negative association with melanocytic naevi. Int J Cancer (1998) 1.03
A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population. Am J Transplant (2012) 1.02
Coverage of the English national human papillomavirus (HPV) immunisation programme among 12 to 17 year-old females by area-level deprivation score, England, 2008 to 2011. Euro Surveill (2014) 1.02
12. Cancers in 2010 attributable to ionising radiation exposure in the UK. Br J Cancer (2011) 1.02
A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH. Oncogene (2006) 1.01
Effects of epidermal growth factor and dimethylhydrazine on crypt size, cell proliferation, and crypt fission in the rat colon. Cell proliferation and crypt fission are controlled independently. Am J Pathol (1997) 0.98
6. Cancers attributable to dietary factors in the UK in 2010. III. Low consumption of fibre. Br J Cancer (2011) 0.96
4. Cancers attributable to dietary factors in the UK in 2010. I. Low consumption of fruit and vegetables. Br J Cancer (2011) 0.96
11. Cancers attributable to infection in the UK in 2010. Br J Cancer (2011) 0.93
Non-Hodgkin's lymphoma and skin cancer. Ultraviolet light is unlikely explanation for association. BMJ (1995) 0.93
10. Cancers attributable to exposure to hormones in the UK in 2010. Br J Cancer (2011) 0.93
Melanoma yield, number of biopsies and missed melanomas in a British teaching hospital pigmented lesion clinic: a 9-year retrospective study. Br J Dermatol (1999) 0.93
How common is the atypical mole syndrome phenotype in apparently sporadic melanoma? J Am Acad Dermatol (1993) 0.92
Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy. Br J Cancer (2010) 0.91
14. Cancers attributable to occupational exposures in the UK in 2010. Br J Cancer (2011) 0.90
Characteristics of HPV infection over time in European women who are HIV-1 positive. BJOG (2012) 0.86
Routine audit is an ethical requirement of screening. BMJ (2001) 0.86
15. Cancers attributable to reproductive factors in the UK in 2010. Br J Cancer (2011) 0.85
Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial. Br J Cancer (2011) 0.85
Photoadaptation to ultraviolet (UV) radiation in vivo: photoproducts in epidermal cells following UVB therapy for psoriasis. Br J Dermatol (2000) 0.83
Risk of ocular melanoma in relation to cutaneous and iris naevi. Int J Cancer (1995) 0.83
Evaluation of long-term survival: use of diagnostics and robust estimators with Cox's proportional hazards model. Stat Med (1996) 0.82
7. Cancers attributable to dietary factors in the UK in 2010. IV. Salt. Br J Cancer (2011) 0.81
Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers. Cytopathology (2012) 0.81
Beta-papillomaviruses and psoriasis: an intra-patient comparison of human papillomavirus carriage in skin and hair. Br J Dermatol (2008) 0.81
Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing. Br J Cancer (2012) 0.80
Phenocopies in families seen by cancer geneticists. J Med Genet (2007) 0.79
Natural history of cervical human papillomavirus. Lancet (2001) 0.78
Modelling the likely effect of the increase of the upper age limit from 70 to 73 for breast screening in the UK National Programme. Stat Methods Med Res (2010) 0.77
Screening mammography and socioeconomic inequalities in breast cancer survival. Ann Oncol (2011) 0.75
Third generation oral contraceptives. Full description of controls is needed in study. BMJ (1996) 0.75
Endometrial cancer during tamoxifen treatment. Lancet (1994) 0.75
Effect of introducing a restrictive cervical screening policy on the detection of cervical cancer. Cytopathology (1991) 0.75
STD and inflammatory cervical cytology. Genitourin Med (1994) 0.75
Cervical screening: what is the point? Lancet (1995) 0.75
A prospective double-blind cross-sectional study of the accuracy of the use of dry vaginal tampons for self-sampling of human papillomaviruses. BJOG (2014) 0.75
Cervical screening in the United Kingdom. Hong Kong Med J (1999) 0.75